stella
beta
Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure — Stella
Recruiting
Back to NSCLC (Non-small Cell Lung Cancer) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality
View full record on ClinicalTrials.gov